Fasting Glucose and HbA1c: Reading Your Metabolic Health
Two blood-sugar numbers — a fasting snapshot and a three-month average — reveal how well your metabolism is coping, often years before anything is labelled 'diabetes.'
Glucose is the body's main fuel, and keeping it in a narrow range is one of metabolism's core jobs. When that control slips — gradually, usually silently — blood sugar drifts up and, over years, damages blood vessels and tissues. Two simple blood tests, fasting glucose and HbA1c, let you see how that control is holding, well before it becomes a named disease.
The two numbers
Fasting glucose is a snapshot: your blood sugar after not eating overnight. HbA1c (glycated haemoglobin) is different and complementary — it reflects your average blood sugar over roughly the previous two to three months, because glucose sticks to haemoglobin in proportion to how much is around. Together they show both the current level and the recent trend.
Standard thresholds mark a continuum: a fasting glucose of 100–125 mg/dL (5.6–6.9 mmol/L) or an HbA1c of 5.7–6.4% is 'prediabetes'; higher is diabetes (American Diabetes Association, 2024). But risk does not switch on at a line — it rises across the range, which is why the numbers matter even when they are 'not quite' abnormal.
Why high glucose ages the body
When blood sugar runs high, glucose reacts with proteins throughout the body — a process called glycation that forms 'advanced glycation end-products.' Over time this stiffens and damages tissues, especially the delicate lining of blood vessels, the kidneys, nerves and the retina. HbA1c itself is a glycation product, which is why it doubles as both a marker and a small window onto that damage.
The consequences reach far beyond a diabetes label: elevated glucose drives cardiovascular disease, kidney and nerve damage, and is linked to cognitive decline — much of it accumulating quietly during the years of 'just slightly high' readings.
Why they track with longevity
Large pooled studies show the risk climbs continuously. Across 102 prospective studies, higher fasting glucose was associated with greater risk of cardiovascular disease, with risk rising even within the pre-diabetic range (Emerging Risk Factors Collaboration, 2010). In adults without diagnosed diabetes, HbA1c predicted future heart disease and death, adding information beyond fasting glucose alone (Selvin et al., 2010).
So these are not just diabetes tests — they are graded markers of how well your metabolism is protecting your vessels and organs over time.
What actually improves them
The good news is that metabolic drift is highly modifiable. In two landmark randomised trials, structured lifestyle change — modest weight loss, more physical activity and a better diet — cut the progression from prediabetes to type 2 diabetes by roughly half or more (Tuomilehto et al., 2001; Diabetes Prevention Program Research Group, 2002), outperforming medication in those studies.
Practically: losing excess weight (especially around the waist), moving regularly, building muscle, and reducing refined carbohydrates and sugary drinks all lower glucose and HbA1c. Get both numbers tested periodically and, if they are creeping up, act early and discuss them with a qualified professional — the earlier the intervention, the more of the trajectory you can bend.
References
Emerging Risk Factors Collaboration (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 375(9733), 2215–2222.
Selvin E. et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800–811.
Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393–403.
Tuomilehto J. et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344(18), 1343–1350.
American Diabetes Association (2024). Classification and diagnosis of diabetes: Standards of Care in Diabetes—2024. Diabetes Care, 47(Suppl 1), S20–S42.
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ExplainerMedicine and treatmentFlat feet in children and adolescents: when to observe, when to treat, and what the evidence shows
In most children a flat foot is a shape, not a disease: the arch matures on its own in the first decade. What decides is whether the foot is flexible and whether it hurts. What the insole trials showed, how a rigid foot differs from a flexible one, when surgery is discussed at all, and what to ask the orthopaedic surgeon.
16 min read
ExplainerBiomarkersWhat limits VO2max — lungs, heart or muscles — and how accurate the estimates are
VO2max is often described as a measure of the lungs. In healthy people the ceiling is set mostly by how much oxygen the heart and blood can deliver; the lungs become the limit only in particular situations. What changes with age, and how accurate lab tests, formulas and watches are.
12 min read
ExplainerSleepMouth breathing during sleep in children: why it is not a habit, and what the treatment evidence shows
An open mouth at night usually means breathing through the nose or throat is harder, but the sign alone does not make a diagnosis. How sleep-disordered breathing in children and teenagers is confirmed, what trials of adenotonsillectomy, medicines, nasal treatment, orthodontics and exercises found, and where evidence is still missing.
15 min read